These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 10135032)

  • 1. CBO report refutes drug industry's fear of reform hurting R&D.
    Wagner L
    Mod Healthc; 1994 Jul; 24(28):36. PubMed ID: 10135032
    [No Abstract]   [Full Text] [Related]  

  • 2. Industry must communicate value and contribution of drugs to Congress and public.
    Gatty B
    Hosp Formul; 1994 May; 29(5):406, 405. PubMed ID: 10133903
    [No Abstract]   [Full Text] [Related]  

  • 3. Health care reform and the pharmaceutical industry.
    Mossinghoff GJ
    Health Care Manag; 1994 Aug; 1(1):187-96. PubMed ID: 10152353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinton's breakthrough drug committee: will it stifle new drug development?
    Gatty B
    Hosp Formul; 1993 Nov; 28(11):946, 945. PubMed ID: 10130236
    [No Abstract]   [Full Text] [Related]  

  • 5. US drug industry's research support.
    Clemmitt M
    Nature; 1993 Feb; 361(6414):757-60. PubMed ID: 8441474
    [No Abstract]   [Full Text] [Related]  

  • 6. The significance of health care reform for research, innovations, and academic medicine.
    Pardes H
    Ann N Y Acad Sci; 1994 Nov; 729():132-8; discussion 139-42. PubMed ID: 7998725
    [No Abstract]   [Full Text] [Related]  

  • 7. The health care industry's challenge.
    Tsongas PF
    Health Syst Rev; 1994; 27(3):7-10. PubMed ID: 10134517
    [No Abstract]   [Full Text] [Related]  

  • 8. Does health care reform require killing managed competition?
    Telling FW
    Clin Perform Qual Health Care; 1994; 2(1):40-1. PubMed ID: 10135443
    [No Abstract]   [Full Text] [Related]  

  • 9. $50 M for drug comparisons could produce valuable results.
    Carroll J
    Manag Care; 2004 Apr; 13(4):9-10. PubMed ID: 15146713
    [No Abstract]   [Full Text] [Related]  

  • 10. HC reform update and drug discounting.
    Lewis WR
    J Healthc Mater Manage; 1994 Mar; 12(3):56-7. PubMed ID: 10134607
    [No Abstract]   [Full Text] [Related]  

  • 11. Health care reform's price fight.
    Stone PH
    Natl J (Wash); 1994 Aug; 26(33):1923-4. PubMed ID: 10139263
    [No Abstract]   [Full Text] [Related]  

  • 12. The visible hand. Clinton's health reform could alter prospects for millions of enterprises.
    Collins S
    US News World Rep; 1993 Oct; 115(13):78-9, 82-6. PubMed ID: 10129437
    [No Abstract]   [Full Text] [Related]  

  • 13. The American Heart Association's 2008 Statement of Principles for Healthcare Reform.
    Gibbons RJ; Jones DW; Gardner TJ; Goldstein LB; Moller JH; Yancy CW;
    Circulation; 2008 Nov; 118(21):2209-18. PubMed ID: 18820173
    [No Abstract]   [Full Text] [Related]  

  • 14. Health care reform: pharmaceutical industry sees itself as 'whipping boy'.
    Gatty B
    Hosp Formul; 1993 Oct; 28(10):872, 871. PubMed ID: 10129137
    [No Abstract]   [Full Text] [Related]  

  • 15. Medical innovation meets healthcare reform.
    White JH
    Health Prog; 1994; 75(6):14-6, 32. PubMed ID: 10135162
    [No Abstract]   [Full Text] [Related]  

  • 16. 'Cure acceleration' funds woven into health reform legislation.
    Wadman M
    Nat Med; 2010 Feb; 16(2):135. PubMed ID: 20134439
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharma spends big to buy influence.
    Nat Med; 2010 Mar; 16(3):243. PubMed ID: 20208486
    [No Abstract]   [Full Text] [Related]  

  • 18. GOP outlines reform deal: panel finds drugmakers key to passage.
    Daly R
    Mod Healthc; 2012 Jun; 42(23):8-9. PubMed ID: 22745964
    [No Abstract]   [Full Text] [Related]  

  • 19. Price controls in the pharmaceutical industry could hurt medical education.
    Hull AR
    Nephrol News Issues; 1993 Jun; 7(6):46-7. PubMed ID: 8133929
    [No Abstract]   [Full Text] [Related]  

  • 20. Health care reform in motion. Canadian RNs see promise despite problems.
    Fuller C
    Revolution (Oakl); 2004; 5(5):6-7. PubMed ID: 15575100
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.